Shantha’s Pentavalent Pediatric Vaccine prequalified by World Health Organization

Shan5(TM)¬†is the first vaccine jointly developed by the Indian company¬†and its parent company Sanofi Pasteur WHO’s decision allows for the purchase of Shan5(TM) by United Nations agencies May 5, 2014 Sanofi Pasteur, the vaccines division of Sanofi, announced today that its pediatric pentavalent vaccine Shan5(TM), developed and manufactured by its affiliate Shantha Biotechnics in Hyderabad, India, has received prequalification status …